“Atropisomeric” Drugs: Basic Concept and Example of Application to Drug Development

Raffa, Robert B. and Pergolizzi, Joseph V. and Taylor, Robert (2020) “Atropisomeric” Drugs: Basic Concept and Example of Application to Drug Development. Pharmacology & Pharmacy, 11 (01). pp. 1-8. ISSN 2157-9423

[thumbnail of pp_2020010614592490.pdf] Text
pp_2020010614592490.pdf - Published Version

Download (1MB)

Abstract

Many therapeutic drugs are racemates; i.e. they are chiral molecules consisting of “left”- and “right-handed” enantiomers (stereoisomers that are mirror images of each other, and are non-superimposable). In some cases, both enantiomers of the drug contribute to some extent (or equally) to the therapeutic effect; in other cases they contribute not at all. The same is true for the adverse effects of racemate drugs: the adverse effects of a racemate drug can be greater-than, less-than, or equal to one or the other enantiomer. An unusual situation arises when a drug consists of “atropisomers”, stereoisomers arising because of hindered rotation about a single chemical bond. We summarize the concept of atropisomerism, and give examples.

Item Type: Article
Subjects: OA Library Press > Chemical Science
Depositing User: Unnamed user with email support@oalibrarypress.com
Date Deposited: 03 Mar 2023 09:21
Last Modified: 20 Jul 2024 09:26
URI: http://archive.submissionwrite.com/id/eprint/275

Actions (login required)

View Item
View Item